PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.
about
Platelet-derived growth factor (PDGF)-C inhibits neuroretinal apoptosis in a murine model of focal retinal degeneration.Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progressionIL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.VEGF-independent angiogenic pathways induced by PDGF-C.Targeting of junctional adhesion molecule-C inhibits experimental choroidal neovascularizationMorpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularizationVasoprotective effect of PDGF-CC mediated by HMOX1 rescues retinal degeneration.VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells.Development of gene therapy for treatment of age-related macular degeneration.PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway.PDGFR-β as a positive regulator of tissue repair in a mouse model of focal cerebral ischemiaSubretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.PDGFRα plays a crucial role in connective tissue remodeling.Hepatic stellate cells in liver development, regeneration, and cancer.Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fatDetection of aqueous VEGF concentrations before and after intravitreal injection of anti-VEGF antibody using low-volume sampling paper-based ELISA.PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently.The abluminal endothelial membrane in neurovascular remodeling in health and disease.Platelet-derived growth factors and their receptors: structural and functional perspectives.Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor.Microenvironmental regulation of tumour angiogenesis.Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts.A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma.Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.PDGF/PDGFR axis in the neural systems.Choroidal pericytes promote subretinal fibrosis after experimental photocoagulation.
P2860
Q33690414-3324E40E-04B2-4798-962B-9EF65FF7F5D3Q33866927-B67D3F69-BCA5-49D5-8237-C5313804E023Q34064081-753EEC42-281D-4553-AFE7-C3D5F7E8E0D9Q34149273-42A9F933-AFCD-4D17-8424-E4C3EAC92FA5Q34155901-F268FD80-986F-4139-AAA5-09DFB1C70569Q34206305-AAFFBBE3-19B1-490B-AB65-E3EA2D4E67A4Q34383796-AF36B3D6-CF86-4915-94BF-4BD711ABEDB9Q34972337-3681C4CD-3B58-4859-BDEE-0B1D519D8DB6Q35101210-2382DB13-91C8-4890-9D3F-6624CB65673AQ35192906-5A979D79-C418-4204-9C8A-403ED179C79CQ35553645-4814065A-7EDA-4E95-8BFB-00DF8CA739A1Q35738314-1D35C0F3-719B-40EB-8FD0-569896F8A3BFQ35896048-BFA17605-AF71-4376-BE93-4A6EED6E66D6Q36350600-26CC6CF6-1B33-4893-B5C8-5EC999531F85Q36793474-3CB2AF3A-C923-4AFF-8C31-169934CCEED8Q37166149-C10717A7-23E9-4217-9A3C-D39A8C40A80FQ37325295-D7EAD9B0-391F-4F3B-A86D-C13E76A5E0A9Q37718460-BAD81F3C-D543-47A6-80E6-CBB96495524EQ38032676-926456BE-A6F2-477E-803E-11D65574BC5EQ38058615-F43AF9E4-F06B-49D8-9D4C-9B9DEBB77FCFQ38844997-718D4B35-5C5F-4728-9713-66170DE8A59CQ39433862-95465A5A-A30A-4329-9269-EBB11C2D5537Q41175151-0332508F-7756-4E9E-81E6-6CDB0D0DEDEBQ41817953-4BB57818-8571-4F85-87CD-2092E5897EEBQ42071408-51F41492-ABDB-4CA6-BC3B-F4CF04BD34CDQ44756866-6EC50BEF-B94F-4174-9A72-9FDB470574A0Q50153431-8BF685FD-2916-4FE6-B52C-8FA93C754F99Q52603912-B1CEB8A2-A370-42C4-8E64-CA2368FF9A26
P2860
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@ast
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@en
type
label
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@ast
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@en
prefLabel
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@ast
PDGF-CC blockade inhibits path ...... ellular and molecular targets.
@en
P2093
P2860
P50
P356
P1476
PDGF-CC blockade inhibits path ...... cellular and molecular targets
@en
P2093
Anil Kumar
Baoying Liu
Chunsik Lee
Johan Lennartsson
Lijin Dong
Pachiappan Arjunan
Peter Colosi
Piotr Wardega
P2860
P304
12216-12221
P356
10.1073/PNAS.1004143107
P407
P577
2010-06-21T00:00:00Z